Gout and Hyperuricaemia in the USA: Prevalence and Trends

Gurkirpal Singh; Bharathi Lingala; Alka Mithal


Rheumatology. 2019;58(12):2177-2180. 

In This Article


In 2015–16, the overall prevalence of self-reported gout among US adults was 3.9%, corresponding to a total affected population of 9.2 million. Reported gout was significantly more prevalent in men (5.2%) compared with women (2.7%) and the prevalence increased with age (Table 1). Hyperuricaemia (>0.40 mmol/l or 6.8 mg/dl) was seen in 14.6% of the US population (estimated 32.5 million individuals) and was much more common in men (24.7%) compared with women (5.2%). The alternative definition of hyperuricaemia (>0.36 mmol/l or 6.0 mg/dl) was seen in 29.9% of individuals (estimated 66.6 million adults). Hyperuricaemia >0.48 mmol/l (8.0 mg/dl) was seen in 4.1% of the population. Both hyperuricaemia and gout were less prevalent in Mexican Americans compared with Whites and African Americans (Table 1). No significant trends were identified in the age-adjusted prevalence of gout and hyperuricaemia. The 2007–08 and 2015–16 age-adjusted rates were not statistically significantly different.